Arteris 10% owner sells 70,000 AIP shares

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported open-market sales of 70,000 shares of AIP common stock.

(Very High)

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Bayview Legacy, LLC, a 10% owner of Arteris, Inc., reported open-market sales of 70,000 shares of AIP common stock. The sales occurred on June 8, 2026 in two tranches at weighted average prices of $34.7417 and $35.1596 per share.

The filing states that these transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025. All holdings are reported as indirect, through Bayview Legacy, LLC, which is controlled by K. Charles Janac as manager.

Insider Trade Summary 10b5-1

Net Seller: 70,000 shares

Net Sell 2 txns

Insider Bayview Legacy, LLC

Role 10% Owner

Sold 70,000 shs ($2.44M)

Type	Security	Shares	Price	Value
Sale	Common Stock	42,449	$34.7417	$1.47M
Sale	Common Stock	27,551	$35.1596	$969K

Holdings After Transaction: Common Stock — 8,929,071 shares (Indirect, See Footnote)

Footnotes (5)

F1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on March 5, 2025.
F2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.
F3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.97 to $34.96 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.
F5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.97 to $35.46 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold total: 70,000 shares First block sold: 27,551 shares at $35.1596/share Second block sold: 42,449 shares at $34.7417/share +2 more

5 metrics

Shares sold total 70,000 shares Net shares sold by Bayview Legacy, LLC on June 8, 2026

First block sold 27,551 shares at $35.1596/share Open-market sale of Arteris common stock

Second block sold 42,449 shares at $34.7417/share Open-market sale of Arteris common stock

Lower price range $33.97–$34.96 Range for trades averaged at $34.7417

Higher price range $34.97–$35.46 Range for trades averaged at $35.1596

Key Terms

Rule 10b5-1 trading plan, weighted average sale price, beneficially owned, voting and dispositive power, +1 more

5 terms

Rule 10b5-1 trading plan regulatory

"Transaction made pursuant to a 10b5-1 trading plan that was adopted..."

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

weighted average sale price financial

"The price reported in Column 4 is a weighted average sale price."

beneficially owned financial

"shares beneficially owned by Bayview Legacy, LLC."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

voting and dispositive power regulatory

"deemed to have voting and dispositive power over the shares..."

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider activity did Arteris (AIP) report in this Form 4?

Arteris (AIP) reported that Bayview Legacy, LLC, a 10% owner, sold 70,000 shares of common stock in open-market transactions. The sales were split into two trades at different weighted average prices on June 8, 2026.

How many Arteris (AIP) shares did Bayview Legacy, LLC sell and at what prices?

Bayview Legacy, LLC sold a total of 70,000 Arteris (AIP) common shares. One block of 27,551 shares sold at a weighted average of $35.1596 per share, and another 42,449 shares sold at a weighted average of $34.7417 per share.

Were the recent Arteris (AIP) insider sales made under a 10b5-1 plan?

Yes. The filing states the Arteris (AIP) share sales were made under a Rule 10b5-1 trading plan. This plan was adopted by K. Charles Janac, as manager of Bayview Legacy, LLC, on March 5, 2025, before the reported transactions.

Who controls Bayview Legacy, LLC in relation to Arteris (AIP) insider holdings?

Bayview Legacy, LLC’s Arteris (AIP) holdings are controlled by K. Charles Janac. The filing notes that he is the manager of Bayview Legacy, LLC and is deemed to have voting and dispositive power over the shares beneficially owned by the LLC.

How are the Arteris (AIP) insider sales by Bayview Legacy, LLC priced within the trading ranges?

The filing reports weighted average sale prices for Arteris (AIP) shares. One set of transactions ranged from $33.97 to $34.96, averaged at $34.7417, and another ranged from $34.97 to $35.46, averaged at $35.1596 per share.

Does the Arteris (AIP) Form 4 mention separate reporting by K. Charles Janac?

Yes. The Form 4 notes that K. Charles Janac has separately filed his own Form 4. That separate filing also reports the same transactions, reflecting his beneficial ownership of Arteris (AIP) shares through Bayview Legacy, LLC, which he manages.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/10/2026 - 04:18 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bayview Legacy, LLC

(Last)

(First)

(Middle)

C/O ARTERIS, INC.

900 E. HAMILTON AVE., SUITE 300

(Street)

CAMPBELL

CALIFORNIA

95008

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Arteris, Inc. [ AIP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/08/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	06/08/2026		S⁽¹⁾⁽²⁾		42,449	D	$34.7417⁽³⁾	8,956,622	I	See Footnote⁽⁴⁾
Common Stock	06/08/2026		S⁽¹⁾⁽²⁾		27,551	D	$35.1596⁽⁵⁾	8,929,071	I	See Footnote

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Transaction made pursuant to a 10b5-1 trading plan that was adopted by K. Charles Janac, as the manager of Bayview Legacy, LLC, on March 5, 2025.

2. K. Charles Janac, in his individual capacity, has separately filed a Form 4 on the date hereof reporting the same transaction given his beneficial ownership of the reported security through Bayview Legacy, LLC, which he controls as its manager.

3. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.97 to $34.96 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

4. K. Charles Janac is the manager of Bayview Legacy, LLC and as such is deemed to have voting and dispositive power over the shares beneficially owned by Bayview Legacy, LLC.

5. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.97 to $35.46 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ K. Charles Janac	06/10/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR